Urinary metabolites of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole in the dog.
The antiprotozoal drug 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole (I), which exhibits activity against trypanosomiasis, is also antibacterial in vivo. Since the urine from a dog dosed with I showed a broader spectrum of antibacterial activity than I itself, metabolites from this urine were isolated and partially characterized. The metabolites were mono- and dihydroxy-substituted species with the hydroxyl groups on carbons 4--7 of the hexahydrobenzisoxazole ring. These observations led to the synthesis of several such hydroxy derivatives of I, and their properties fully supported the proposed positions of metabolic hydroxylation. One synthetic compound, the 6,7-cis-dihydroxy compound, exhibited higher antibacterial activity against Salmonella schottmuelleri in mice and greater trypanocidal activity in vivo against Trypanosoma cruzi (Brazil strain) than I.
D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology / Q000652:urine*; D001711:Biotransformation; D014355:Chagas Disease / Q000188:drug therapy; D002849:Chromatography, Gas; D004285:Dogs; D005260:Female; D007555:Isoxazoles / Q000494:pharmacology / Q000652:urine*; D013058:Mass Spectrometry; D051379:Mice; D009593:Nitroimidazoles / Q000494:pharmacology / Q000652:urine*; D010080:Oxazoles / Q000652:urine*; D012475:Salmonella / Q000187:drug effects
D000981:Antiprotozoal Agents; D007555:Isoxazoles; D009593:Nitroimidazoles; D010080:Oxazoles